Preview

Злокачественные опухоли

Расширенный поиск

Мастэктомия: рождение, эволюция и современное значение в лечении и профилактике рака молочной железы

https://doi.org/10.18027/2224-5057-2015-4-3-13

Полный текст:

Аннотация

На протяжении более ста лет мастэктомия была символом радикального лечения рака молочной железы. Разработанный в конце XIX века этот вид оперативного вмешательства претерпел значительные изменения в результате изучения вопросов распространения опухолевого процесса. В статье описаны исторические аспекты попыток хирургического лечения рака молочной железы, история создания радикальных подходов к лечению рака и органосохраняющего лечения. Описаны современные модификации мастэктомии в комбинации с одномоментной реконструкцией, такие как кожесохраняющая и с сохранением сосково-ареолярного комплекса, обсуждены показания и результаты их применения в современной хирургической практике.

Об авторе

Сергей Евгеньевич Малыгин
ГБОУ ВПО РНИМУ им. Н.И. Пирогова Минздрава России
Россия

к.м.н., доцент кафедры онкологии и лучевой терапии,

Москва



Список литературы

1. Wagner FB, Martin RG, Bland KI. History of the therapy of breast disease. In: Bland KI, Copeland EM, eds. The Breast: Comprehensive Management of Benign and Malignant Diseases. 2nd ed. Philadelphia, PA: WB Saunders; 1991:1–18. Olson JS, ed. Bathsheba’s Breast. Women, Cancer, & History. Baltimore.

2. Halsted WS. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894.Ann Surg. 1894 Nov;20(5): 497–555.

3. W. Meyer, “An improved method of the radical operation for carcinoma of the breast,” New YorkMedical Record, vol. 46, pp.746–749, 1894.

4. Halsted WS The Results of Radical Operations for the Cure of Carcinoma of the Breast.Ann Surg. 1907 Jul;46(1):1–19.

5. Zurrida S, Bassi F, Arnone P et al. The Changing Face of Mastectomy (from Mutilation to Aid to Breast Reconstruction). Int J Surg Oncol. Epub Vol.2011, 2011.

6. Barron H. Lerner The Breast Cancer Wars: Fear, Hope and the Pursuit of a Cure in Twentieth Century America Journal of the Royal Society of Medicine. 2003 October; 96(10)516.

7. Haagensen CD, Stout AP. CARCINOMA OF THE BREASTPART I; RESULTS OF TREATMENT. Ann Surg. 1942 Dec;116(6):801–15.

8. D.H. Patey and W.H. Dyson, “The prognosis of carcinoma of the breast in relation to the type of the mastectomy performed,” British Journal of Cancer, vol. 2, pp. 7–13, 1948.

9. Murphy, J. B.: Carcinoma of Breast. Surgical Clinics of J.B. Murphy, I:(No. 6), 779(Dec.),1912.

10. J. L. Madden, S. Kandalaft, and R.A. Bourque, “Modified radical mastectomy,” Annals of Surgery, vol. 175, no. 5, pp. 624–634, 1972.

11. B. Fisher, “Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer,” Cancer, vol. 40, supplement 1, pp. 574–587, 1977.

12. S. Kaae and H. Johansen, “Simple mastectomy plus postoperative irradiation by the method of McWhirter for mammary carcinoma,” Annals of Surgery, vol. 170, no. 6, pp. 895–899, 1969.

13. Atkins H, Hayward JL, Klugman DJ, Wayte AB. Treatment of early breast cancer: a report after ten years of a clinical trial. Br Med J. 1972 May 20;2(5811):423–9.

14. Huvos A G, Hutter R V, Berg J W Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg. 1971 January; 173(1): 44–46.

15. Berg, J. W.: The Significance of Axillary Node Levels in the Study of Breast Carcinoma.Cancer, 8:776, 1955.

16. U. Veronesi, R. Saccozzi, M. Del Vecchio et al., “Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast,”The New England Journal of Medicine, vol. 305, no. 1, pp. 6–11,1981.

17. B. Fisher, M. Bauer, R. Margolese et al., “Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer,” The New England Journal of Medicine, vol. 312, no. 11, pp. 665–673, 1985.

18. U. Veronesi, N. Cascinelli, L. Mariani et al., “Twenty year follow-up of a randomized study comparing breast conserving surgery with radical mastectomy for early breast cancer,” The New England Journal of Medicine, vol. 347, no. 16, pp. 1227–1232, 2002.

19. B. Fisher, S. Anderson, J. Bryant et al., “Twenty-year followup of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer,” The New England Journal of Medicine, vol. 347, no. 16, pp. 1233–1241, 2002.

20. Van Steen A, Van Tiggelen R. Short history of mammography: a Belgian perspective. JBR-BTR. 2007 May-Jun;90(3):151–3.

21. Maxwell GP. Iginio Tansini and the origin of the latissimus dorsi musculocutaneous flap.Plast Reconstr Surg. 1980 May;65(5):686–92.

22. Schneider W J, Hill H L, Brown R G. Latissimus dorsi myocutaneous flap for breast reconstruction. Br J Plast Surg. 1977;30:277–281.

23. Snyderman RK, Guthrie RH. Reconstruction of the female breast following radical mastectomy.Plast Reconstr Surg. 1971 Jun;47(6):565–7.

24. Bostwick J 3rd, Vasconez LO, Jurkiewicz MJ. Breast reconstruction after a radical mastectomy.Plast Reconstr Surg. 1978 May;61(5):682–93.

25. C.R. Hartrampf, M. Scheflan, and P.W. Black, “Breast reconstruction with a transverse abdominal island flap” Plastic and Reconstructive Surgery, vol. 69, no. 2, pp. 216–225, 1982.

26. B.A. Toth and P. Lappert, “Modified skin incisions for mastectomy: the need for plastic surgical input in preoperative planning,” Plastic and Reconstructive Surgery, vol. 87, no. 6, pp.1048–1053, 1991.

27. Carlson GW, Bostwick J 3rd, Styblo TM, et al. Ann Surg. Skin-sparing mastectomy. Oncologic and reconstructive considerations. 1997 May;225(5):570–5; discussion 575–8.

28. Kroll SS, Schusterman MA, Tadjalli HE et al. Risk of recurrence after treatment of early breast cancer with skin-sparing mastectomy. Ann Surg Oncol. 1997 AprMay;4(3):193–7.

29. Baum M. Modern concepts of the natural history of breast cancer: A guide to the design and publication of trials of the treatment of breast cancer. Eur J Cancer. 2013 Jan;49(1):60–4.

30. Carlson GW, Styblo TM, Lyles RH et al. Local recurrence after skin-sparing mastectomy: tumor biology or surgical conservatism? Ann Surg Oncol. 2003 Mar;10(2):108–12.

31. Meretoja TJ, Rasia S, von Smitten KA et al. Late results of skin-sparing mastectomy followed by immediate breast reconstruction., Br J Surg. 2007 Oct;94(10):1220–5.

32. Carlson GW, Bostwick J 3rd, Styblo TM, Moore B, Bried JT, Murray DR, Wood WC.Skin-sparing mastectomy. Oncologic and reconstructive considerations.Ann Surg. 1997 May;225(5):570–5; discussion 575–8.

33. Малыгин Е.Н., Малыгин С.Е. Мастэктомия с сохранением кожи молочной железы и одномоментной реконструкцией с использованием нижнего ректо-абдоминального лоскута // Анн. пластич., реконструкт. и эстетич. хир., 1997 № 3, с. 47–52. (Malygin E., Malygin S. Skin-sparing mastectomy and immediate breast reconstruction using lower rectus abdiminis muscle flap // Ann. Plast. Reconst. and Aesthet. Surg 1997 #3 p.47–52).

34. Slavin SA, Schnitt SJ, Duda RB, Houlihan MJ, Koufman CN, Morris DJ, Troyan SL, Goldwyn RM. Skin-sparing mastectomy and immediate reconstruction: oncologic risks and aesthetic

35. results in patients with early-stage breast cancer. Plast Reconstr Surg. 1998 Jul;102(1):49–62.

36. Gabka CJ, Maiwald G, Bohmert H. Immediate breast reconstruction for breast carcinoma using the periareolar approach. Plast Reconstr Surg. 1998 Apr;101(5):1228–34).

37. Carlson GW, Grossl N, Lewis MM, Temple JR, Styblo TM. Preservation of the inframammary fold: what are we leaving behind? Plast Reconstr Surg. 1996 Sep;98(3):447–50.

38. Barton FE Jr, English JM, Kingsley WB, Fietz M. Glandular excision in total glandular mastectomy and modified radical mastectomy: a comparison. Plast Reconstr Surg. 1991;88 (3):389–394.

39. Simmons RM, Fish SK, Gayle L et al. Local and distant recurrence rates in skin-sparing mastectomies compared with non-skin-sparing mastectomies.Ann Surg Oncol. 1999 OctNov;6(7):676–81.

40. Малыгин С. Е. Одномоментная реконструкция молочной железы при раке с использованием ректоабдоминального лоскута. Дисс. канд. мед. наук.– М., 2000,– 152 с. (Malygin S. Immediate breast reconstruction using rectus abdiminis muscle flap in breast cancer patients. PhD paper work Moscow 2000, 152 pages).

41. Nava MB, Cortinovis U, Ottolenghi J et al Skin-reducing mastectomy. Plast Reconstr Surg. 2006 Sep;118(3):603–10; discussion 611–3).

42. Freeman BS. Subcutaneous mastectomy for benign breast lesions with immediate or delayed prosthetic replacement. Plast Reconstr Surg Transplant Bull. 1962;30:676–682.

43. Hinton CP, Doyle PJ, Blarney RW, Davies CJ, Holliday HW, Elston CW. Subcutaneous mastectomy for primary operable breast cancer. Br J Surg. 1984;71:469–472.

44. Laronga C, Kemp B, Johnston D, et al. The incidence of occult nippleareola complex involvement in breast cancer patients receiving a skin-sparing mastectomy. Ann Surg Oncol. 1999;6(6):609–613.

45. Simmons RM, Brennan M, Christos P, et al. Analysis of nipple/areolar involvement with mastectomy: can the areola be preserved? Ann Surg Oncol.2002;9(2):165–168.

46. Laronga C, Robb GL, Singletary SE. Feasibility of skin-sparing mastectomy with preservation of the nipple-areola complex. Breast Dis Yearb Q. 1998;19(2):125–127.

47. Gerber B, Krause A, Reimer T, et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg. 2003;238(1):120–127.

48. Petit JY, Veronesi U, Orecchia R, et al. Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the

49. European Institute of Oncology of Milan (EIO). Breast Cancer Res Treat. 2009;117(2):333–338.

50. Domchek SM, Friebel TM, Singer CF. Association of riskreducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA. 2010 Sep 1;304(9):967–75).

51. Rebbeck TR, Friebel T, Lynch HT, et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSEStudy Group. J Clin Oncol. 2004;22(6):1055–1062.


Для цитирования:


Малыгин С.Е. Мастэктомия: рождение, эволюция и современное значение в лечении и профилактике рака молочной железы. Злокачественные опухоли. 2015;(4):3-13. https://doi.org/10.18027/2224-5057-2015-4-3-13

For citation:


Malygin S.E. The role of mastectomy in treatment and prophylaxis of breast cancer: beginning, evolution and recent changes. Malignant tumours. 2015;(4):3-13. (In Russ.) https://doi.org/10.18027/2224-5057-2015-4-3-13

Просмотров: 553


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2224-5057 (Print)
ISSN 2587-6813 (Online)